R01HD107695
Project Grant
Overview
Grant Description
Pubertal, Psychological, and Physiological Development in Females with Autism - Project Summary/Abstract
Puberty is among the most complex developmental transitions over the human lifetime. The timing (age of onset) and tempo (rate of change) of puberty can significantly and negatively impact physical, psychosocial, and physiological functioning, especially in females. Autism Spectrum Disorder (ASD) is characterized by impaired reciprocal social communication and poor adaptation to change; thus, the onset and course of puberty marks a pivotal transition.
In a series of cross-sectional studies, findings from the study team have shown the following:
1) Advanced pubertal timing for female youth with ASD compared to typically developing females (i.e., breast development, menses) using rigorous assessment of pubertal staging.
2) Distinct camouflaging behaviors in females with ASD when socially interacting with peers.
3) Higher depressive symptoms in early adolescents with ASD, especially females.
4) Sex-based differences in neural socioemotional processing in youth with ASD.
5) Elevated stress and arousal in youth with ASD compared to same-age typically developing peers that increases with age and pubertal development.
Consistent across these studies is the unique profile of females with ASD and the potential deleterious impact of early puberty in this vulnerable, understudied population and developmental window.
While the previous and ongoing pubertal development research is compelling, at the start of enrollment, 80% of the 10-year-old females with ASD had already entered puberty compared to 29% of the typically developing group. Therefore, the true onset of puberty could not be determined. Moreover, it was based on a relatively small sample of females with ASD aged 10-13 years (N = 35). Thus, a comprehensive exploration of pubertal maturation in a large sample of younger girls with ASD is needed.
The overarching goal is to systematically examine the precise onset, tempo, and course of pubertal, psychosocial, and physiological development in females with ASD using a multimodal, multimethod, accelerated longitudinal design. A large sample of females with ASD (N=120) and typically developing (TD) (N=120) spanning 6 to 15 years will be followed over four years: Cohort 1 enrolled at 6 years (follow 6-9), Cohort 2 enrolled at 8 years (follow 8-11), Cohort 3 enrolled at 10 years (follow 10-13), and Cohort 4 enrolled at 12 years (follow 12-15).
The aims will address three key areas:
Aim 1: Pubertal Development - Will examine the timing, tempo, and course of puberty based on physical development (Tanner stage (TS), body mass index (BMI), height, linear growth velocity (LGV)), hormones (estradiol, luteinizing hormone (LH)), and menstrual cycle.
Aim 2: Psychosocial Profiles - Will examine reciprocal social communication (CASS) and internalizing symptoms (anxiety and depression) at the onset and over the course of pubertal development.
Aim 3: Physiological Characterization - Will simultaneously examine social functioning at the level of the central nervous system (EEG hyperscanning), HPA axis (cortisol), and peripheral nervous system (RSA) during naturalistic social interactions between same-sex peers.
The findings will reveal the impact of the onset, tempo, and course of puberty on females with ASD to improve education, inform services, and develop interventions, which are lacking.
Puberty is among the most complex developmental transitions over the human lifetime. The timing (age of onset) and tempo (rate of change) of puberty can significantly and negatively impact physical, psychosocial, and physiological functioning, especially in females. Autism Spectrum Disorder (ASD) is characterized by impaired reciprocal social communication and poor adaptation to change; thus, the onset and course of puberty marks a pivotal transition.
In a series of cross-sectional studies, findings from the study team have shown the following:
1) Advanced pubertal timing for female youth with ASD compared to typically developing females (i.e., breast development, menses) using rigorous assessment of pubertal staging.
2) Distinct camouflaging behaviors in females with ASD when socially interacting with peers.
3) Higher depressive symptoms in early adolescents with ASD, especially females.
4) Sex-based differences in neural socioemotional processing in youth with ASD.
5) Elevated stress and arousal in youth with ASD compared to same-age typically developing peers that increases with age and pubertal development.
Consistent across these studies is the unique profile of females with ASD and the potential deleterious impact of early puberty in this vulnerable, understudied population and developmental window.
While the previous and ongoing pubertal development research is compelling, at the start of enrollment, 80% of the 10-year-old females with ASD had already entered puberty compared to 29% of the typically developing group. Therefore, the true onset of puberty could not be determined. Moreover, it was based on a relatively small sample of females with ASD aged 10-13 years (N = 35). Thus, a comprehensive exploration of pubertal maturation in a large sample of younger girls with ASD is needed.
The overarching goal is to systematically examine the precise onset, tempo, and course of pubertal, psychosocial, and physiological development in females with ASD using a multimodal, multimethod, accelerated longitudinal design. A large sample of females with ASD (N=120) and typically developing (TD) (N=120) spanning 6 to 15 years will be followed over four years: Cohort 1 enrolled at 6 years (follow 6-9), Cohort 2 enrolled at 8 years (follow 8-11), Cohort 3 enrolled at 10 years (follow 10-13), and Cohort 4 enrolled at 12 years (follow 12-15).
The aims will address three key areas:
Aim 1: Pubertal Development - Will examine the timing, tempo, and course of puberty based on physical development (Tanner stage (TS), body mass index (BMI), height, linear growth velocity (LGV)), hormones (estradiol, luteinizing hormone (LH)), and menstrual cycle.
Aim 2: Psychosocial Profiles - Will examine reciprocal social communication (CASS) and internalizing symptoms (anxiety and depression) at the onset and over the course of pubertal development.
Aim 3: Physiological Characterization - Will simultaneously examine social functioning at the level of the central nervous system (EEG hyperscanning), HPA axis (cortisol), and peripheral nervous system (RSA) during naturalistic social interactions between same-sex peers.
The findings will reveal the impact of the onset, tempo, and course of puberty on females with ASD to improve education, inform services, and develop interventions, which are lacking.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Nashville,
Tennessee
37203
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 353% from $734,311 to $3,322,864.
Vanderbilt University Medical Center was awarded
Pubertal Development in Females with Autism: Timing, Tempo, and Impact
Project Grant R01HD107695
worth $3,322,864
from the National Institute of Child Health and Human Development in September 2022 with work to be completed primarily in Nashville Tennessee United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.865 Child Health and Human Development Extramural Research.
The Project Grant was awarded through grant opportunity Research on Autism Spectrum Disorders (R01 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
9/1/22
Start Date
6/30/27
End Date
Funding Split
$3.3M
Federal Obligation
$0.0
Non-Federal Obligation
$3.3M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01HD107695
Transaction History
Modifications to R01HD107695
Additional Detail
Award ID FAIN
R01HD107695
SAI Number
R01HD107695-3313160944
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NT00 NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development
Funding Office
75NT00 NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development
Awardee UEI
GYLUH9UXHDX5
Awardee CAGE
7HUA5
Performance District
TN-05
Senators
Marsha Blackburn
Bill Hagerty
Bill Hagerty
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Child Health and Human Development, National Institutes of Health, Health and Human Services (075-0844) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,432,594 | 100% |
Modified: 6/22/26